STAAR Surgical Company
STAA
$25.26
-$0.61-2.36%
NASDAQ
| 06/27/2025 | 03/28/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.06% | -12.99% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.06% | -12.99% | |||
| Cost of Revenue | -21.00% | -15.71% | |||
| Gross Profit | 17.12% | -11.51% | |||
| SG&A Expenses | -3.73% | 3.30% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -10.73% | 0.61% | |||
| Operating Income | 28.90% | -24.53% | |||
| Income Before Tax | 52.44% | -79.62% | |||
| Income Tax Expenses | -3,210.18% | -107.06% | |||
| Earnings from Continuing Operations | 68.99% | -58.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 68.99% | -58.38% | |||
| EBIT | 28.90% | -24.53% | |||
| EBITDA | 29.87% | -26.97% | |||
| EPS Basic | 69.10% | -58.12% | |||
| Normalized Basic EPS | 35.30% | -4.76% | |||
| EPS Diluted | 69.09% | -58.32% | |||
| Normalized Diluted EPS | 35.30% | -4.76% | |||
| Average Basic Shares Outstanding | 0.36% | 0.16% | |||
| Average Diluted Shares Outstanding | 0.36% | 0.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||